New system offers simultaneous ablations with an intuitive touch screen generator, potentially enabling faster procedure times for the treatment of hypertension ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc. (STJ), a glo...
Devices, Interventional, Cardiology
St. Jude Medical, EnligHTN III trial, EnligHTN, Renal Denervation

IRVINE, Calif.--(Healthcare Sales & Marketing Network)--Reverse Medical Corporation today announced the initial clinical use of their MVP™ Micro Vascular Plug system for peripheral artery embolization. The device has been granted CE Mark approval to obstru...
Devices, Interventional, Regulatory
Reverse Medical, Micro Vascular Plug, embolization

ORANGEBURG, N.Y., May 13, 2013 -- (Healthcare Sales & Marketing Network) -- Vision-Sciences, Inc. (VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that ...
Devices, Personnel
Vision-Sciences, EndoSheath

JERSEY CITY, N.J., May 13, 2013 -- (Healthcare Sales & Marketing Network) -- Optimer Pharmaceuticals (OPTR) (the "Company" or "Optimer") today announced the appointment of Mr. Eric Sirota as Chief Operating Officer. Mr. Sirota will be...
Biopharmaceuticals, Personnel
Optimer Pharmaceuticals, DIFICID , fidaxomicin

Proceeds to Drive Continued Sales Force Expansion and New Product Launches BROOMFIELD, Colo., May 13, 2013 -- (Healthcare Sales & Marketing Network) -- Lanx, Inc., a privately held global spine company focused on developing and commercializing innovativ...
Devices, Neurosurgery, Orthopaedic
Lanx, TIMBERLINE, Lateral Fusion, ASPEN MIS, spine surgery

New Prospective Data Presented on 1,000 Patients at 2013 Heart Rhythm Society Shows >90% Fewer Major Device Infections DENVER--(Healthcare Sales & Marketing Network)--Use of TYRX, Inc.’s AIGISRx® Antibacterial Envelope reduced major infection...
Devices, Cardiology
TYRX, AIGISRx, Antibacterial Envelope

DENVER--(Healthcare Sales & Marketing Network)--Sorin Group (SRN.MI), (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, today announced it received FDA approval for and is beginning the U.S. launch ...
Devices, Cardiology, FDA, Product Launch
Sorin Group, SMARTVIEW, remote monitoring, PARADYM RF, ICD

Late-breaking data presented at Heart Rhythm Society’s 2013 Annual Meeting show benefits compared with single chamber devices sustained in long-term follow-up DENVER--(Healthcare Sales & Marketing Network)--Sorin Group (SRN.MI), (Reuters Code: SORN.MI),...
Devices, Cardiology
Sorin Group, implantable cardioverter defibrillator, OPTION study, ICD therapy

Late-breaking data presented at Heart Rhythm Society’s 2013 Annual Meeting show benefits compared with single chamber devices sustained in long-term follow up DENVER--(Healthcare Sales & Marketing Network)--Sorin Group (SRN.MI), a global medical company...
Devices, Cardiology
Sorin Group, implantable cardioverter defibrillator, ICD

Company Offers Mapping System with IntellaMap Orion™ Mapping Catheter in Effort to Significantly Enhance Physician Treatment Options NATICK, Mass., May 10, 2013 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) has receiv...
Devices, Cardiology, Regulatory
Boston Scientific, Rhythmia Mapping, IntellaMap Orion, electrophysiology

OAB patients treated with Urgent® PC over 36 months sustained their urinary symptom improvement MINNEAPOLIS, May 10, 2013 -- (Healthcare Sales & Marketing Network) -- Uroplasty, Inc. (UPI), a medical device company that develops, manufactures and m...
Devices, Urology
Uroplasty, STEP Study, PTNS, overactive bladder, Urgent PC, Neuromodulation

Expands Global Erivedge Patient Access and Commercial Opportunity LEXINGTON, Mass., May 10, 2013 -- (Healthcare Sales & Marketing Network) -- Curis, Inc. (CRIS), an oncology-focused company seeking to develop next generation targeted drug candidates for...
Biopharmaceuticals, Oncology, Regulatory
Curis , Erivedge, vismodegib, basal cell carcinoma

Ilaris® (canakinumab) is the first interleukin-1 beta inhibitor for the treatment of SJIA and the only treatment approved specifically for SJIA that is given as a monthly subcutaneous injection(1) In Phase III studies, 84% of Ilaris-treated SJIA pat...
Biopharmaceuticals. FDA
Novartis, Ilaris, canakinumab, SJIA, systemic juvenile idiopathic arthritis

DUBLIN, Ireland, May 9, 2013 -- (Healthcare Sales & Marketing Network) -- Warner Chilcott plc (WCRX) today announced that the United States Food and Drug Administration (FDA) has approved a new oral contraceptive, norethindrone acetate and ethinyl estradio...
Biopharmaceuticals, FDA
Warner Chilcott, norethindrone acetate, ethinyl estradiol, contraceptive

Bedridden for Months, 41-Year-Old Father of Five Was Walking Again Two Weeks after Implant TUCSON, Ariz., May 9, 2013 -- (Healthcare Sales & Marketing Network) -- When Alfred Williams was admitted to Ochsner Medical Center in December, the 41-year-old ...
Devices, Cardiology
SynCardia Systems, temporary Total Artificial Heart, bridge to transplant

WALTHAM, Mass., May 9, 2013 -- (Healthcare Sales & Marketing Network) -- BG Medicine, Inc. (BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, today announced that it has appointed Paul Sohmer, M.D....
Diagnostics, Cardiology, Personnel
BG Medicine, CardioSCORE

ABBOTT PARK, Ill., May 9, 2013 -- (Healthcare Sales & Marketing Network) -- Abbott (ABT) today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c (HbA1c) test, which may aid physicians in diagnos...
Diagnostics, Endocrinology, Regulatory
Abbott, HbA1c, ARCHITECT clinical chemistry, A1c, diabetes

Acquisition of Marketing Rights to FDA Approved Therapy Expands Company's Cystic Fibrosis Portfolio CARY, NC--(Healthcare Sales & Marketing Network) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on commercia...
Biopharmaceuticals, Acquisitions
Cornerstone Therapeutics, Digestive Care Inc, PERTZYE, pancrelipase, PANCRECARB

EDEN PRAIRIE, MN--(Healthcare Sales & Marketing Network) - Sunshine Heart, Inc. (NASDAQ: SSH) announced today the implant of the first patient in the OPTIONS HF C-Pulse System Multicenter Study. The post market study is intended to treat patients with mode...
Devices, Cardiology
Sunshine Heart, OPTIONS HF, C-Pulse System, Heart Assist System

Adasuve® (loxapine) inhalation powder is approved in the U.S. for the acute treatment of agitation associated with schizophrenia and bipolar disorder NORTH WALES, Pa. & MOUNTAIN VIEW, Calif.--(Healthcare Sales & Marketing Network)--Teva Pharmaceuti...
Biopharmaceuticals, Licensing
Teva Pharmaceutical, Alexza Pharmaceuticals, ADASUVE, loxapine